Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 2
2006 2
2007 1
2008 3
2009 1
2010 2
2011 1
2012 3
2013 1
2014 3
2015 4
2016 1
2017 3
2018 2
2019 4
2020 1
2021 7
2022 9
2023 4

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
CAR-NK Cells: A Chimeric Hope or a Promising Therapy?
Sabbah M, Jondreville L, Lacan C, Norol F, Vieillard V, Roos-Weil D, Nguyen S. Sabbah M, et al. Cancers (Basel). 2022 Aug 8;14(15):3839. doi: 10.3390/cancers14153839. Cancers (Basel). 2022. PMID: 35954502 Free PMC article. Review.
However, with recent advances in manufacturing engineered CAR-NK cells exploiting their cytolytic capacities, antibody-dependent cellular cytotoxicity (ADCC), and cytokine production, "off-the-shelf" allogeneic CAR-NK cells can provide a great potential in cancer treatment …
However, with recent advances in manufacturing engineered CAR-NK cells exploiting their cytolytic capacities, antibody-dependent cellular cy …
Osteopontin as a Regulator of Colorectal Cancer Progression and Its Clinical Applications.
Amilca-Seba K, Sabbah M, Larsen AK, Denis JA. Amilca-Seba K, et al. Among authors: sabbah m. Cancers (Basel). 2021 Jul 28;13(15):3793. doi: 10.3390/cancers13153793. Cancers (Basel). 2021. PMID: 34359694 Free PMC article. Review.
A high expression of the phosphoprotein osteopontin (OPN) has been associated with cancer progression in several tumor types, including breast cancer, hepatocarcinoma, ovarian cancer, and colorectal cancer (CRC). ...We examine how epigenetic and geneti …
A high expression of the phosphoprotein osteopontin (OPN) has been associated with cancer progression in several tumor types, includi …
The Use of microRNAs in the Management of Endometrial Cancer: A Meta-Analysis.
Delangle R, De Foucher T, Larsen AK, Sabbah M, Azaïs H, Bendifallah S, Daraï E, Ballester M, Mehats C, Uzan C, Canlorbe G. Delangle R, et al. Among authors: sabbah m. Cancers (Basel). 2019 Jun 16;11(6):832. doi: 10.3390/cancers11060832. Cancers (Basel). 2019. PMID: 31208108 Free PMC article. Review.
Introduction: Endometrial cancer (EC) is the most important gynecological cancer in terms of incidence. microRNAs (miRs), which are post-transcriptional regulators implicated in a variety of cellular functions including carcinogenesis, are particularly attractive ca …
Introduction: Endometrial cancer (EC) is the most important gynecological cancer in terms of incidence. microRNAs (miRs), whic …
Clinical Value and Molecular Function of Circulating MicroRNAs in Endometrial Cancer Regulation: A Systematic Review.
Bloomfield J, Sabbah M, Castela M, Mehats C, Uzan C, Canlorbe G. Bloomfield J, et al. Among authors: sabbah m. Cells. 2022 Jun 3;11(11):1836. doi: 10.3390/cells11111836. Cells. 2022. PMID: 35681531 Free PMC article. Review.
This systematic review of literature highlights the different microRNAs circulating in the serum or plasma of endometrial cancer patients and their association with clinical and prognostic characteristics in endometrial cancer. ...
This systematic review of literature highlights the different microRNAs circulating in the serum or plasma of endometrial cancer pati …
MicroRNA as Epigenetic Modifiers in Endometrial Cancer: A Systematic Review.
Favier A, Rocher G, Larsen AK, Delangle R, Uzan C, Sabbah M, Castela M, Duval A, Mehats C, Canlorbe G. Favier A, et al. Among authors: sabbah m. Cancers (Basel). 2021 Mar 6;13(5):1137. doi: 10.3390/cancers13051137. Cancers (Basel). 2021. PMID: 33800944 Free PMC article. Review.
The objective of this systematic review is to summarize our current knowledge on the influence of miRNAs in the epigenetic deregulation of tumor-related genes in endometrial cancer (EC). We conducted a literature search on the role of miRNAs in the epigenetic regulation of …
The objective of this systematic review is to summarize our current knowledge on the influence of miRNAs in the epigenetic deregulation of t …
Molecular and pathological signatures of epithelial-mesenchymal transitions at the cancer invasion front.
De Wever O, Pauwels P, De Craene B, Sabbah M, Emami S, Redeuilh G, Gespach C, Bracke M, Berx G. De Wever O, et al. Among authors: sabbah m. Histochem Cell Biol. 2008 Sep;130(3):481-94. doi: 10.1007/s00418-008-0464-1. Epub 2008 Jul 22. Histochem Cell Biol. 2008. PMID: 18648847 Free PMC article. Review.
Reduction of epithelial cell-cell adhesion via the transcriptional repression of cadherins in combination with the acquisition of mesenchymal properties are key determinants of epithelial-mesenchymal transition (EMT). EMT is associated with early stages of carcinogenesis, canc …
Reduction of epithelial cell-cell adhesion via the transcriptional repression of cadherins in combination with the acquisition of mesenchyma …
Retraction: miR-661 expression in SNAI1-induced epithelial to mesenchymal transition contributes to breast cancer cell invasion by targeting Nectin-1 and StarD10 messengers.
Vetter G, Saumet A, Moes M, Vallar L, Le Béchec A, Laurini C, Sabbah M, Arar K, Theillet C, Lecellier CH, Friederich E. Vetter G, et al. Among authors: sabbah m. Oncogene. 2016 Feb 11;35(6):670. doi: 10.1038/onc.2015.265. Epub 2015 Dec 14. Oncogene. 2016. PMID: 32667144 Free PMC article.
Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.
Sabbah M, Emami S, Redeuilh G, Julien S, Prévost G, Zimber A, Ouelaa R, Bracke M, De Wever O, Gespach C. Sabbah M, et al. Drug Resist Updat. 2008 Aug-Oct;11(4-5):123-51. doi: 10.1016/j.drup.2008.07.001. Epub 2008 Aug 20. Drug Resist Updat. 2008. PMID: 18718806 Review.
New therapeutic combinations using genotoxic agents and/or EMT signaling inhibitors are therefore expected to circumvent the chemotherapeutic resistance of cancers characterized by transient or sustained EMT signatures. Thus, targeting critical orchestrators at the converg …
New therapeutic combinations using genotoxic agents and/or EMT signaling inhibitors are therefore expected to circumvent the chemotherapeuti …
Extracellular Vesicles in Breast Cancer: From Biology and Function to Clinical Diagnosis and Therapeutic Management.
Loric S, Denis JA, Desbene C, Sabbah M, Conti M. Loric S, et al. Among authors: sabbah m. Int J Mol Sci. 2023 Apr 13;24(8):7208. doi: 10.3390/ijms24087208. Int J Mol Sci. 2023. PMID: 37108371 Free PMC article. Review.
Breast cancer (BC) is the first worldwide most frequent cancer in both sexes and the most commonly diagnosed in females. ...This review intends to cover the most recent literature on the role of extracellular vesicle production in normal and cancerous breast …
Breast cancer (BC) is the first worldwide most frequent cancer in both sexes and the most commonly diagnosed in females. ...Th …
The C-Terminal Acidic Tail Modulates the Anticancer Properties of HMGB1.
Borde C, Dillard C, L'Honoré A, Quignon F, Hamon M, Marchand CH, Faccion RS, Costa MGS, Pramil E, Larsen AK, Sabbah M, Lemaire SD, Maréchal V, Escargueil AE. Borde C, et al. Among authors: sabbah m. Int J Mol Sci. 2022 Jul 17;23(14):7865. doi: 10.3390/ijms23147865. Int J Mol Sci. 2022. PMID: 35887213 Free PMC article.
Energy metabolism reprogramming was recently listed as a hallmark of cancer. In this process, the switch from pyruvate kinase isoenzyme type M1 to pyruvate kinase isoenzyme type M2 (PKM2) is believed to play a crucial role. ...In this work, we report that the deletion of t …
Energy metabolism reprogramming was recently listed as a hallmark of cancer. In this process, the switch from pyruvate kinase isoenzy …
49 results